Oral spray wintertime vitamin D3 supplementation has no impact on inflammation in Gaelic footballers

Joshua Todd, Emeir M McSorley, L. Kirsty Pourshahidi, Sharon Madigan, William Crowe, Eamon Laird, Martin Healy, Andrea McNeilly, Pamela Magee

Research output: Contribution to journalArticle

Abstract

Vitamin D inadequacy [total 25(OH)D <50 nmol/L] is widespread in athletes. The biologically active metabolite, 1,25‐dihydroxyvitamin D, may be involved in regulating inflammation although in vitro findings have not been consistently replicated in human intervention trials. This study, conducted at a latitude of 55°N, aimed to assess inflammatory biomarkers in Gaelic footballers before and after a wintertime vitamin D3 intervention. Samples from a 12‐week double‐blind, randomized, placebo‐controlled trial, in which 42 Gaelic footballers received 3000 IU (75 μg) vitamin D3 daily or placebo via oral spray solutions, were analysed for a range of inflammatory biomarkers. Cytokines (interleukin‐8 and tumor necrosis factor‐α), cathelicidin and high sensitivity C‐reactive protein were quantified by multiplex assay, enzyme‐linked immunosorbent assay and clinical biochemistry, respectively. White blood cell, lymphocyte, and neutrophil concentrations were determined by full blood profile. Data on total 25‐hydroxyvitamin D, measured by LC‐MS/MS, were available from the previous study. Vitamin D3 supplementation significantly increased mean total 25‐hydroxyvitamin D concentrations from 47 to 84 nmol/L (P = 0.006); yet this had no effect on white blood cell count (P = 0.699), lymphocyte (P = 0.694), neutrophil (P = 0.594), interleukin‐8 (P = 0.334), tumor necrosis factor‐α (P = 0.587), cathelicidin (P = 0.745) or high sensitivity C‐reactive protein concentration (P = 0.621) compared to placebo. 12‐weeks vitamin D3 supplementation did not impact the immune profile of Gaelic footballers. This is likely because biomarkers were within their respective normal range or at a concentration similar to that of the general population at baseline. Future studies are encouraged to use inflammation as their primary outcome measure and recruit athletes at risk of compromised immunity.
LanguageEnglish
Pages1300-1307
Number of pages8
JournalScandinavian Journal of Medicine & Science in Sports
Volume27
Issue number11
Early online date5 Oct 2016
DOIs
Publication statusPublished - 30 Nov 2017

Fingerprint

Oral Sprays
Cholecalciferol
Inflammation
Biomarkers
Placebos
Interleukin-8
Athletes
C-Reactive Protein
Neutrophils
Tumor Necrosis Factor-alpha
Lymphocytes
Leukocyte Count
Vitamin D
Biochemistry
Immunity
Reference Values
Leukocytes
Randomized Controlled Trials
Enzyme-Linked Immunosorbent Assay
Outcome Assessment (Health Care)

Keywords

  • vitamin D
  • oral spray
  • inflammation
  • athletes
  • supplementation

Cite this

@article{e3a451f60f6145769e0fb766b3240532,
title = "Oral spray wintertime vitamin D3 supplementation has no impact on inflammation in Gaelic footballers",
abstract = "Vitamin D inadequacy [total 25(OH)D <50 nmol/L] is widespread in athletes. The biologically active metabolite, 1,25‐dihydroxyvitamin D, may be involved in regulating inflammation although in vitro findings have not been consistently replicated in human intervention trials. This study, conducted at a latitude of 55°N, aimed to assess inflammatory biomarkers in Gaelic footballers before and after a wintertime vitamin D3 intervention. Samples from a 12‐week double‐blind, randomized, placebo‐controlled trial, in which 42 Gaelic footballers received 3000 IU (75 μg) vitamin D3 daily or placebo via oral spray solutions, were analysed for a range of inflammatory biomarkers. Cytokines (interleukin‐8 and tumor necrosis factor‐α), cathelicidin and high sensitivity C‐reactive protein were quantified by multiplex assay, enzyme‐linked immunosorbent assay and clinical biochemistry, respectively. White blood cell, lymphocyte, and neutrophil concentrations were determined by full blood profile. Data on total 25‐hydroxyvitamin D, measured by LC‐MS/MS, were available from the previous study. Vitamin D3 supplementation significantly increased mean total 25‐hydroxyvitamin D concentrations from 47 to 84 nmol/L (P = 0.006); yet this had no effect on white blood cell count (P = 0.699), lymphocyte (P = 0.694), neutrophil (P = 0.594), interleukin‐8 (P = 0.334), tumor necrosis factor‐α (P = 0.587), cathelicidin (P = 0.745) or high sensitivity C‐reactive protein concentration (P = 0.621) compared to placebo. 12‐weeks vitamin D3 supplementation did not impact the immune profile of Gaelic footballers. This is likely because biomarkers were within their respective normal range or at a concentration similar to that of the general population at baseline. Future studies are encouraged to use inflammation as their primary outcome measure and recruit athletes at risk of compromised immunity.",
keywords = "vitamin D, oral spray, inflammation, athletes, supplementation",
author = "Joshua Todd and McSorley, {Emeir M} and Pourshahidi, {L. Kirsty} and Sharon Madigan and William Crowe and Eamon Laird and Martin Healy and Andrea McNeilly and Pamela Magee",
note = "UIR Compliant - dates from UIR have been added to PURE Portal Link",
year = "2017",
month = "11",
day = "30",
doi = "10.1111/sms.12785",
language = "English",
volume = "27",
pages = "1300--1307",
journal = "Scandinavian Journal of Medicine & Science in Sports",
issn = "0905-7188",
number = "11",

}

TY - JOUR

T1 - Oral spray wintertime vitamin D3 supplementation has no impact on inflammation in Gaelic footballers

AU - Todd, Joshua

AU - McSorley, Emeir M

AU - Pourshahidi, L. Kirsty

AU - Madigan, Sharon

AU - Crowe, William

AU - Laird, Eamon

AU - Healy, Martin

AU - McNeilly, Andrea

AU - Magee, Pamela

N1 - UIR Compliant - dates from UIR have been added to PURE Portal Link

PY - 2017/11/30

Y1 - 2017/11/30

N2 - Vitamin D inadequacy [total 25(OH)D <50 nmol/L] is widespread in athletes. The biologically active metabolite, 1,25‐dihydroxyvitamin D, may be involved in regulating inflammation although in vitro findings have not been consistently replicated in human intervention trials. This study, conducted at a latitude of 55°N, aimed to assess inflammatory biomarkers in Gaelic footballers before and after a wintertime vitamin D3 intervention. Samples from a 12‐week double‐blind, randomized, placebo‐controlled trial, in which 42 Gaelic footballers received 3000 IU (75 μg) vitamin D3 daily or placebo via oral spray solutions, were analysed for a range of inflammatory biomarkers. Cytokines (interleukin‐8 and tumor necrosis factor‐α), cathelicidin and high sensitivity C‐reactive protein were quantified by multiplex assay, enzyme‐linked immunosorbent assay and clinical biochemistry, respectively. White blood cell, lymphocyte, and neutrophil concentrations were determined by full blood profile. Data on total 25‐hydroxyvitamin D, measured by LC‐MS/MS, were available from the previous study. Vitamin D3 supplementation significantly increased mean total 25‐hydroxyvitamin D concentrations from 47 to 84 nmol/L (P = 0.006); yet this had no effect on white blood cell count (P = 0.699), lymphocyte (P = 0.694), neutrophil (P = 0.594), interleukin‐8 (P = 0.334), tumor necrosis factor‐α (P = 0.587), cathelicidin (P = 0.745) or high sensitivity C‐reactive protein concentration (P = 0.621) compared to placebo. 12‐weeks vitamin D3 supplementation did not impact the immune profile of Gaelic footballers. This is likely because biomarkers were within their respective normal range or at a concentration similar to that of the general population at baseline. Future studies are encouraged to use inflammation as their primary outcome measure and recruit athletes at risk of compromised immunity.

AB - Vitamin D inadequacy [total 25(OH)D <50 nmol/L] is widespread in athletes. The biologically active metabolite, 1,25‐dihydroxyvitamin D, may be involved in regulating inflammation although in vitro findings have not been consistently replicated in human intervention trials. This study, conducted at a latitude of 55°N, aimed to assess inflammatory biomarkers in Gaelic footballers before and after a wintertime vitamin D3 intervention. Samples from a 12‐week double‐blind, randomized, placebo‐controlled trial, in which 42 Gaelic footballers received 3000 IU (75 μg) vitamin D3 daily or placebo via oral spray solutions, were analysed for a range of inflammatory biomarkers. Cytokines (interleukin‐8 and tumor necrosis factor‐α), cathelicidin and high sensitivity C‐reactive protein were quantified by multiplex assay, enzyme‐linked immunosorbent assay and clinical biochemistry, respectively. White blood cell, lymphocyte, and neutrophil concentrations were determined by full blood profile. Data on total 25‐hydroxyvitamin D, measured by LC‐MS/MS, were available from the previous study. Vitamin D3 supplementation significantly increased mean total 25‐hydroxyvitamin D concentrations from 47 to 84 nmol/L (P = 0.006); yet this had no effect on white blood cell count (P = 0.699), lymphocyte (P = 0.694), neutrophil (P = 0.594), interleukin‐8 (P = 0.334), tumor necrosis factor‐α (P = 0.587), cathelicidin (P = 0.745) or high sensitivity C‐reactive protein concentration (P = 0.621) compared to placebo. 12‐weeks vitamin D3 supplementation did not impact the immune profile of Gaelic footballers. This is likely because biomarkers were within their respective normal range or at a concentration similar to that of the general population at baseline. Future studies are encouraged to use inflammation as their primary outcome measure and recruit athletes at risk of compromised immunity.

KW - vitamin D

KW - oral spray

KW - inflammation

KW - athletes

KW - supplementation

U2 - 10.1111/sms.12785

DO - 10.1111/sms.12785

M3 - Article

VL - 27

SP - 1300

EP - 1307

JO - Scandinavian Journal of Medicine & Science in Sports

T2 - Scandinavian Journal of Medicine & Science in Sports

JF - Scandinavian Journal of Medicine & Science in Sports

SN - 0905-7188

IS - 11

ER -